JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.96 / 10
Netural
Jasper Therapeutics' fundamental score is 3.95/10, indicating neutral to weak health. Key concerns include a low Gross profit margin (36.7%) and negative PB-ROE (-0.46), while Profit-MV (0.47) and Net income-Revenue (-0.15) show mixed signals. The stock ranks in lower quartiles for several valuation and efficiency metrics, historically underperforming on one-month returns, which underscores the need for selective investment approaches.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score1/3
Weight9.76%
1M Return5.63%
Value-0.26
Score1/3
Weight9.76%
1M Return5.63%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.28%
1M Return0.22%
Value36.70
Score1/3
Weight0.28%
1M Return0.22%
Net income-Revenue
Value-0.15
Score2/3
Weight13.85%
1M Return8.04%
Value-0.15
Score2/3
Weight13.85%
1M Return8.04%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.42%
1M Return1.75%
Value1.78
Score2/3
Weight2.42%
1M Return1.75%
Asset-MV
Value-0.51
Score3/3
Weight28.48%
1M Return14.63%
Value-0.51
Score3/3
Weight28.48%
1M Return14.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight8.94%
1M Return5.89%
Value47.88
Score3/3
Weight8.94%
1M Return5.89%
Profit-MV
Value0.47
Score2/3
Weight13.66%
1M Return7.95%
Value0.47
Score2/3
Weight13.66%
1M Return7.95%
PB-ROE
Value-0.46
Score0/3
Weight7.01%
1M Return4.05%
Value-0.46
Score0/3
Weight7.01%
1M Return4.05%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.06%
1M Return1.53%
Value7993.84
Score3/3
Weight2.06%
1M Return1.53%
Cash-MV
Value-0.07
Score2/3
Weight13.54%
1M Return7.78%
Value-0.07
Score2/3
Weight13.54%
1M Return7.78%
Revenue-MV
Value-0.26
Score1/3
Weight9.76%
1M Return5.63%
Value-0.26
Score1/3
Weight9.76%
1M Return5.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight8.94%
1M Return5.89%
Value47.88
Score3/3
Weight8.94%
1M Return5.89%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.28%
1M Return0.22%
Value36.70
Score1/3
Weight0.28%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight13.66%
1M Return7.95%
Value0.47
Score2/3
Weight13.66%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight13.85%
1M Return8.04%
Value-0.15
Score2/3
Weight13.85%
1M Return8.04%
PB-ROE
Value-0.46
Score0/3
Weight7.01%
1M Return4.05%
Value-0.46
Score0/3
Weight7.01%
1M Return4.05%
Current assets turnover ratio
Value1.78
Score2/3
Weight2.42%
1M Return1.75%
Value1.78
Score2/3
Weight2.42%
1M Return1.75%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.06%
1M Return1.53%
Value7993.84
Score3/3
Weight2.06%
1M Return1.53%
Asset-MV
Value-0.51
Score3/3
Weight28.48%
1M Return14.63%
Value-0.51
Score3/3
Weight28.48%
1M Return14.63%
Cash-MV
Value-0.07
Score2/3
Weight13.54%
1M Return7.78%
Value-0.07
Score2/3
Weight13.54%
1M Return7.78%
Is JSPR undervalued or overvalued?
- JSPR scores 3.96/10 on fundamentals and holds a Fair valuation at present. Backed by its -182.13% ROE, 0.00% net margin, -0.42 P/E ratio, 3.26 P/B ratio, and -22.53% earnings growth, these metrics solidify its Netural investment rating.
